CTP:phosphocholine cytidylyltransferase (CT) is a rate-limiting and complex
ly regulated enzyme in phosphatidylcholine (PC) biosynthesis and is importa
nt in the adaptation of macrophages to cholesterol loading. The goal of the
present study was to use transgenesis to study the CT reaction in differen
tiated macrophages in vivo. We successfully created macrophage-targeted tra
nsgenic mice that overexpress a truncated form of CT, called CT-314. Sonica
ted homogenates of peritoneal macrophages overexpressing CT-314 protein dem
onstrated a two-fold increase in CT activity in vitro compared with homogen
ates from nontransgenic macrophages. CT-314 macrophages, however, demonstra
ted no increase in CT activity or PC biosynthesis in vivo. This finding cou
ld not be explained simply by intracellular mistargeting of CT-314, by the
inability of CT-314 to associate with cellular membranes, or by substrate l
imitation. To further probe the mechanism, an in vitro assay using intact n
uclei was developed in an attempt to preserve interactions between CT, whic
h is primarily a nuclear enzyme in macrophages, and other nuclear molecules
. This intact-nuclei assay faithfully reproduced the situation observed in
living macrophages, namely, no significant increase in CT activity despite
increased CT-314 protein. In contrast, CT activity in sonicated nuclei from
CT-314 macrophages was substantially higher than that from nontransgenic m
acrophages. Thus, a sonication-sensitive interaction between excess CT and
one or more nuclear molecules may be responsible for the limitation of CT a
ctivity in CT-314 macrophages. These data represent the first report of a C
T transgenic animal and the first study of a differentiated cell type with
excess CT. (C) 1999 Elsevier Science B.V. All rights reserved.